IPO registrations (S-1, F-1) · Registrants
KESTRA MEDICAL TECHNOLOGIES, LTD.
- SEC CIK
- 1877184 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2025-02-10, last 2025-12-01; 2 initial registrations, 2 amendments
- Outcome
- Final prospectus filed 2025-03-06; declared effective 2025-03-05
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- D0
- Business address
- 3933 LAKE WASHINGTON BLVD NE, SUITE 200, Kirkland, WA 98033
- Ticker
- KMTS (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- KESTRA MEDICAL TECHNOLOGIES, LTD. on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2025-02-26)
- Final price
- $17.00 per share, above the range (424B4 filed 2025-03-06, an initial public offering)
- Shares sold
- 11,882,352
- Gross proceeds
- $201,999,984 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol KMTS
- Lead underwriters
- BofA Securities; Goldman Sachs (3,147,936 shares); Piper Sandler (2,375,585 shares)
- Syndicate
- Wells Fargo (1,484,407); Stifel (890,289); Wolfe Research (10,322); Nomura (196,112)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Kestra Medical Technologies, Inc. Fuzzy (name and state)
- SEC filer: KESTRA MEDICAL TECHNOLOGIES, LTD. EXACT (CIK (EXACT))
- Person page: Mary Kay Ladone Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2025-02-10 | S-1 | S-1 (registration) | KESTRA MEDICAL TECHNOLOGIES, LTD. | 0001193125-25-023649 ↗ |
| 2025-02-26 | S-1/A | S-1/A (amendment) | KESTRA MEDICAL TECHNOLOGIES, LTD. | 0001193125-25-035754 ↗ |
| 2025-03-03 | S-1/A | S-1/A (amendment) | KESTRA MEDICAL TECHNOLOGIES, LTD. | 0001193125-25-043885 ↗ |
| 2025-03-05 | S-1MEF | S-1MEF (added securities) | KESTRA MEDICAL TECHNOLOGIES, LTD. | 0001193125-25-047580 ↗ |
| 2025-03-05 | EFFECT | EFFECT (declared effective) | KESTRA MEDICAL TECHNOLOGIES, LTD. | 9999999995-25-000581 ↗ |
| 2025-03-06 | 424B4 | 424B4 (final prospectus) | KESTRA MEDICAL TECHNOLOGIES, LTD. | 0001193125-25-048462 ↗ |
| 2025-12-01 | S-1 | S-1 (registration) | KESTRA MEDICAL TECHNOLOGIES, LTD. | 0001193125-25-303114 ↗ |
| 2025-12-02 | S-1MEF | S-1MEF (added securities) | KESTRA MEDICAL TECHNOLOGIES, LTD. | 0001193125-25-305761 ↗ |
| 2025-12-02 | EFFECT | EFFECT (declared effective) | KESTRA MEDICAL TECHNOLOGIES, LTD. | 9999999995-25-003485 ↗ |
| 2025-12-03 | 424B4 | 424B4 (final prospectus) | KESTRA MEDICAL TECHNOLOGIES, LTD. | 0001193125-25-306986 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-26 | S-1/A | registration statement | $14.00–$16.00 | 10,000,000 | - | Nasdaq KMTS | 7 | primary document; range, shares headline, cover names 7 | document ↗ | |
| 2025-03-03 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2025-03-06 | 424B4 | final prospectus | $17.00 | 11,882,352 | $201,999,984 | Nasdaq KMTS | 7 | primary document; price sentence, shares headline, proceeds table, underwriting table 6, cover names 7 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| AuWerter Toby | Director | 1 | 2025 | ||
| BAIN CAPITAL INVESTORS LLC | TenPercentOwner | 1 | 2025 | ||
| Bain Charger Holdings, L.P. | TenPercentOwner | 1 | 2025 | ||
| Bikoff Maxwell | Director | 1 | 2025 | ||
| COHEN RAYMOND W | Director | 5 | 2025–2026 | ||
| Ford Alfred J Jr | Officer | Chief Commercial Officer | 7 | 2025–2026 | |
| Gordon Christopher R | Director,TenPercentOwner | 1 | 2025 | ||
| Ladone Mary Kay | Director | 3 | 2025–2026 | person page Fuzzy | |
| Mahboob Vaseem | Officer | Chief Financial Officer | 7 | 2025–2026 | |
| Reilly Kevin C | Director | 3 | 2025–2026 | ||
| Schwartz Jeffrey Lawrence | Director,TenPercentOwner | 3 | 2025–2026 | ||
| Umberger Traci S | Director,Officer | See Remarks | 9 | 2025–2026 | |
| Webster Brian Daniel | Director,Officer | See Remarks | 14 | 2025–2026 | |
| Hanley Conor | Director | 3 | 2025–2026 | ||
| Kwo Elizabeth | Director | 4 | 2025–2026 | ||
| Moran Timothy P. | Officer | Chief Business Officer | 6 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Kestra Medical Technologies, Inc. | WA | State business registries | name and state |
| SEC filer | KESTRA MEDICAL TECHNOLOGIES, LTD. | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | Mary Kay Ladone | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, WA first:
- SONOSITE INC WA
- QUINTON CARDIOLOGY SYSTEMS INC WA
- EMULATE THERAPEUTICS, INC. WA
- VIVOS INC WA
- Avalon Holding Group, Inc. WA
- OSR Health, Inc. WA
- MIV THERAPEUTICS INC A1
- BIOCUREX INC A1
- Enox Biopharma Inc A1
- Stimcell Energetics Inc. A1
In other datasets, the same topic (Technology) in WA:
- Form D issuer: 2nd Watch, Inc. (Form D private offerings)
- Lobbying client: 4G AMERICAS (F/K/A 3G AMERICAS LLC) (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology